Hak Chul Jang Selected Research

Hak Chul Jang Research Topics

Disease

54	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2006
33	Insulin Resistance 06/2022 - 11/2006
13	Atherosclerosis 12/2021 - 01/2011
12	Obesity 01/2022 - 01/2006
12	Body Weight (Weight, Body) 01/2022 - 01/2006
8	Coronary Stenosis (Coronary Artery Stenosis) 01/2020 - 07/2009
7	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2019
7	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 11/2014
7	Glucose Intolerance 01/2021 - 02/2011
7	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 05/2011
6	Hyperglycemia 01/2022 - 06/2008
6	Pathologic Constriction (Stenosis) 01/2020 - 07/2009
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 06/2011
6	Hypertension (High Blood Pressure) 09/2017 - 01/2011
5	Hypothyroidism 01/2020 - 06/2009
5	Prediabetic State (Prediabetes) 01/2019 - 11/2014
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 02/2016
5	Dyslipidemias (Dyslipidemia) 01/2018 - 01/2013
4	Inflammation (Inflammations) 06/2022 - 08/2012
4	Sarcopenia 01/2022 - 01/2019
4	Diabetes Mellitus 01/2021 - 01/2011
3	Frailty 01/2022 - 01/2019
3	Non-alcoholic Fatty Liver Disease 12/2021 - 10/2021
3	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 05/2009
3	Hyperthyroidism 01/2020 - 10/2015
3	Abdominal Obesity 06/2019 - 01/2013
3	Thyrotoxicosis 07/2018 - 02/2018
3	Weight Loss (Weight Reduction) 11/2017 - 01/2009
3	Diabetes Complications 10/2017 - 12/2011
3	Thyroid Neoplasms (Thyroid Cancer) 01/2016 - 10/2014
3	Weight Gain 07/2015 - 01/2013
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2014 - 01/2009
2	Fibrosis (Cirrhosis) 12/2021 - 10/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021 - 10/2021
2	Depressive Disorder (Melancholia) 05/2018 - 07/2012
2	Disease Progression 02/2018 - 02/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2009
2	Albuminuria 10/2017 - 01/2009
2	Osteoporosis 07/2014 - 08/2010

Drug/Important Bio-Agent (IBA)

34	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2006
14	Insulin (Novolin)FDA Link 01/2022 - 06/2008
12	CalciumIBA 12/2019 - 07/2009
11	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 01/2009
9	LipidsIBA 01/2019 - 05/2011
7	Triglycerides (Triacylglycerol)IBA 12/2021 - 02/2011
7	CholesterolIBA 12/2021 - 06/2011
7	AdiponectinIBA 01/2021 - 06/2008
6	NAD (NADH)IBA 01/2022 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2011
6	C-Reactive ProteinIBA 01/2019 - 01/2006
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2014
5	Pharmaceutical PreparationsIBA 12/2016 - 06/2012
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 04/2016
4	Apolipoproteins E (ApoE)IBA 12/2021 - 01/2013
4	Thyroid HormonesIBA 01/2020 - 09/2013
4	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 08/2012
4	HDL CholesterolIBA 01/2019 - 11/2006
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018 - 10/2014
4	Peptides (Polypeptides)IBA 10/2017 - 02/2011
4	lobeglitazoneIBA 10/2017 - 01/2014
4	CreatinineIBA 05/2017 - 01/2009
3	Vitamin D FDA LinkGeneric 06/2022 - 01/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2021 - 01/2009
3	Messenger RNA (mRNA)IBA 12/2021 - 09/2012
3	Interleukin-6 (Interleukin 6)IBA 12/2021 - 08/2012
3	AdipokinesIBA 01/2021 - 07/2012
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2012
3	Rosuvastatin Calcium (Crestor)FDA Link 03/2019 - 11/2017
3	Lipoproteins (Lipoprotein)IBA 12/2016 - 09/2013
3	ApolipoproteinsIBA 03/2016 - 01/2013
3	C-PeptideIBA 12/2015 - 04/2011
3	HDL LipoproteinsIBA 06/2014 - 11/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 05/2010
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 06/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2021 - 01/2014
2	Apolipoprotein C-II (ApoC2)IBA 12/2021 - 01/2020
2	fibroblast growth factor 21IBA 11/2021 - 01/2019
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2020 - 06/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 01/2017
2	LigandsIBA 01/2019 - 11/2015
2	glimepiride (Amarel)FDA LinkGeneric 01/2019 - 01/2017
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2018 - 01/2014
2	LC15-0444IBA 01/2018 - 01/2017
2	Antihypertensive Agents (Antihypertensives)IBA 05/2017 - 01/2009
2	AlbuminsIBA 05/2017 - 01/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2017 - 05/2015
2	OsteocalcinIBA 12/2016 - 02/2016
2	N 30IBA 04/2016 - 10/2015
2	pitavastatin (itavastatin)FDA Link 03/2016 - 05/2015
2	AntibodiesIBA 01/2016 - 05/2009
2	bisphenol AIBA 07/2015 - 06/2014
2	voglibose (Basen)IBA 01/2015 - 01/2014
2	AntioxidantsIBA 01/2014 - 01/2011

Therapy/Procedure

17	Therapeutics 01/2022 - 06/2009
4	Glycemic Control 04/2016 - 12/2011
3	Drug Therapy (Chemotherapy) 01/2020 - 07/2008
2	Bariatric Surgery 01/2022 - 01/2022
2	Fitness Trackers 07/2018 - 02/2018
2	Aftercare (After-Treatment) 02/2018 - 05/2017
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2016 - 06/2009